TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

Marc Frahm, Ph.D.

Managing Director, Health Care - Biotechnology

Headshot photo of Marc Frahm

Prior to joining TD Cowen in July 2013, Marc Frahm was a graduate research assistant at Duke University. At Duke, he studied the T-cell response to HIV, the regulation of PD-L1 expression, and developed an in vitro diagnostic method for the differentiation of active and latent TB infections.

Dr. Frahm received a BS in biochemistry from the University of Wisconsin-Madison and his Ph.D. in molecular genetics and microbiology from Duke University.

Get In Touch

Start a conversation with Marc Frahm


    Explore related thought leadership, reports, coverage and insights for Marc Frahm.

    Ahead of the Curve®

    Back to School: Grading FDA Divisions on Regulatory Flexibility   

    Medical researcher conducting pharmaceutical research in a lab. Representing innovative therapies for fighting cancer i.e., immuno-oncology
    Ahead of the Curve®

    Investors Guide to Immuno-Oncology

    A lightbulb planted in soil with a sprout growing from inside it representing our best ESG investment ideas for 2023.

    Best ESG Investment Ideas for 2023